In the natural progression of cancer bone metastasis, the expression of GPR84 was downregulated in the tumor microenvironment; however, activation of GPR84 through 6-OAU, a potent agonist, inhibited osteolysis. This evidence concerns the gene GPR84 and neoplasm.